| Contents | 1 | |
|---|---|---|
| Foreword | 2 | |
| Reference and administrative | details | 3 |
| Acknowledgements | 4 | |
| Structure, governance and management |
4 | |
| Objectives and activities | 7 | |
| Achievements and performance |
7 | |
| Financial review |
11 | |
| Statement ofcorporate trustee | responsibilities | 13 |
| Independent examiner's report |
14 | |
| Statement offinancial activities |
15 | |
| Balance sheet Statement ofcash flows |
1617. | |
| Notes to the accounts | 18 |
| NHS Charities Together | NHS Charities Together | NHS Charities Together | 2123,500 | |
|---|---|---|---|---|
| Individual | donations | received | from various donors | f20,217 |
| Investment | income | interest | 2 5,183 |
| I | ||||||||
|---|---|---|---|---|---|---|---|---|
| Unrestricted | Restricted | Endownrent | Total funds | Total funds | ||||
| 2020/21 | 2020/21 | 2020/21 | 2020/21 | 2019/20 | ||||
| Note | ||||||||
| income and endowments | from: | |||||||
| Donations and legacies |
18,117 | 125,600 | 0 | 143,717 | 4,252 | |||
| income from charitable | activities | 0 | 0 | 0 | 0 | 318 | ||
| Income from inmstments | 5,183 | 0 | 0 | 5183 | 8,551 | |||
| Sub total voluntary income |
23,300 | 125,600 | 0 | 148,900 | 13,121 | |||
| Other income | ||||||||
| Transfer from NHS bodies | ||||||||
| Total income | ||||||||
| 23,300 | 125,600 | 0 | 148,900 | 13,121 | ||||
| Expenditure on: |
||||||||
| Raising funds | (22) | (3,000) | 0 | (3,022) | (290) | |||
| Charitable activities: |
||||||||
| Patient benefit |
(21,466) | (610) | 0 | (22,078) | (90,234) | |||
| Staff benefit | (296) | (31,678) | 0 | (31,974) | (10,977) | |||
| Other | (100) | 0 | 0 | (100) | 0 | |||
| Total | (21,884) | (35,288) | 0 | (67,172) | (101,501) | |||
| Net gains/(losses) on |
investments | 'l2,727 | 0 | 12,727 | (182) | |||
| Net income /(expenditure) | 'i4,143 | 90,312 | 0 | 104,455 | (88,562) | |||
| Transfer between funds |
(30,000) | 30,000 | ||||||
| Other recognised gains/(losses): |
||||||||
| Net moment in funds |
(15,857) | 120,312 | 0 | 104,465 | (88,562) | |||
| Reconciiiadon offunds |
||||||||
| Total income funds brought | forward | 240,000 | 0 | 15,000 | 255,000 | 343,562 | ||
| Total income funds carried forward | 12 | 224,143 | 120,312 | 15,000 | 359,465 | 266,000 |
| Unrestricted | Restricted | Endowment | Total funds | Total funds | ||||
|---|---|---|---|---|---|---|---|---|
| 31 March | 31 March | 31March | 31 March | 31 March | ||||
| 2021 | 2021 | 2021 | 2021 | 2020 | ||||
| Note | ||||||||
| Fixed Assets | ||||||||
| Tangible I Intangible | Assets | |||||||
| Total fixed assets | ||||||||
| Curre nt assets | ||||||||
| Debtors | 9 | 743 | 0 | 0 | 743 | 74,208 | ||
| Cash held at Bank | 10 | 31,386 | 137,291 | 15,000 | 183,677 | 95,365 | ||
| Inwstment | 10 | 202,180 | 0 | 0 | 202,180 | 189,453 | ||
| Total current assets | 234,309 | 137,291 | 15,000 | 386,600 | 359,026 | |||
| Liabilities | ||||||||
| Creditors; amounts | falling | due within one year | 11 | (10,166) | (16,979) | 0 | (27,145) | (104,026) |
| Net current assets | 224,143 | 120,312 | 15,000 | 369,465 | 255,000 | |||
| Total assets less current | liabilities | 224,143 | 120,312 | 15,000 | 359,455 | 255,000 | ||
| Total net assets | 224,143 | 120,312 | 15,000 | 359,455 | 255,000 | |||
| The funds ofthe charity | ||||||||
| Unrestdcted funds |
224,143 | 120,312 | 344,455 | 240,000 | ||||
| Restricted funds |
0 | 0 | 0 | |||||
| Endowment funds |
15,000 | 15,000 | 15,000 | |||||
| Total charity funds | 12 | 224,143 | 120,312 | 15,000 | 359,455 | 255,000 |
| Unrestricted | Restricted | Endowment | Total funds | Total funds | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020/21 | 2020/21 | 2020/21 | 2020/2'f | 2019/20 | |||||||
| 6 | 8 | ||||||||||
| Hots | |||||||||||
| Cash flows fram | operating | activities: | |||||||||
| Net cash provided | by (used | in) operating | activities | 13 | (54,163) | 137,291 | 0 | 83,128 | (10,172) | ||
| Interest received | 5,'I83 | 0 | 5,183 | 8,551 | |||||||
| Change in cash and cash equivalents period |
in | the | reporting | (48,980) | 137,294 | 0 | 88,311 | (1,621) | |||
| Cash and cash equivalents reporting period |
at the beginning | ofthe | 80,366 | 0 | 15,000 | 95,366 | 96,986 | ||||
| Cash and cash equivalents period |
at the end | of | the | reporting | 14 | 3'I,386 | 137,291 | 15,000 | 183,677 | 95,365 |
| Unrestricted | Restricted | Endowment | Total funds | Total funds | |||
|---|---|---|---|---|---|---|---|
| 2020/21 | 2020/21 | 2020/21 | 2020/21 | 2019/20 | |||
| F | |||||||
| Donations; | |||||||
| Adult Secure Unit | 0 | 0 | 0 | 0 | |||
| Manchester | Services | 229 | 0 | 229 | 0 | ||
| Research | & | Innovation | 0 | 0 | 0 | 0 | |
| Restricted | Funds | 0 | 125,600 | 125,600 | 0 | ||
| General Funds |
17,888 | 0 | 17,888 | 4,252 | |||
| Sub Total | 18,117 | 125,600 | 143,717 | 4,252 | |||
| Legacies: | |||||||
| Sub Total | 0 | 0 | |||||
| Total | 18,117 | 125,600 | 143,717 | 4,252 |
| Unrestricted | Restricted | Endowment | Total funds | Total funds | ||
|---|---|---|---|---|---|---|
| 2020/21 | 2020/21 | 2020/21 | 2020/21 | 2019/20 | ||
| F | ||||||
| Fundraising | events | |||||
| Adult Secure | Unit | 0 | 318 | |||
| Total | 318 |
| Unrestricted | Restricted | Endowment | Total funds | Total hnds | ||||
|---|---|---|---|---|---|---|---|---|
| 2020/21 | 2020/21 | 2020/21 | 2020/21 | 2019/20 | ||||
| 6 | ||||||||
| Interest | from | Special Interest | Bearing Account | 49 | 102 | |||
| Interest from investment |
Royal London Asset Management | 5,134 | 5,134 | 8,449 | ||||
| Total | 5,183 | 5,183 | 8,551 |
| Unrestricted | Restricted | Endowment | Total funds | Total funds | |||
|---|---|---|---|---|---|---|---|
| 2020/21 | 2020/21 | 2020/21 | 2020/21 | 2019/20 | |||
| Fundraising | non-pay | costs | 22 | 3,000 | 3,022 | 290 | |
| Total | 22 | 3,000 | 3,022 | 290 |
| Unrestricted | Restri cted | Endowment | Total | |||
|---|---|---|---|---|---|---|
| 2020/21 | 2020/21 | 2020/21 | 2020/21 | |||
| Patient | benefit | (21,466) | (610) | 0 | (22,076) | |
| Staff benefit | (296) | (31,678) | 0 | (311974) | ||
| Total | (21,762) | (32,288) | 0 | (54,050) | ||
| 2019/20 | Activifies underlaken | directly | Total | |||
| Unrestricted | Restricted | Endowment | ||||
| 2019/20 | 2019/20 | 2019/20 ) | 2019/20 | |||
| Patient | benefit | (90,234) | 0 | (90,234) | ||
| Staff benefit | (10,977) | 0 | (10,977) | |||
| Total | (101,211) | 0 | (101,211) |
| Activities undertaken directly Unrestricted Restricted |
Activities undertaken directly Unrestricted Restricted |
Endowment | Total | |
|---|---|---|---|---|
| 2020/21 | 2020/21 | 2020/21 | 2020/21 | |
| Other Expenditure-Research | (100) | (100) | ||
| Total | (100) | 0 | (100) | |
| 2019/20 | Activities undertaken | directly | Total | |
| Unrestricted Restricted |
Endowment | |||
| 2019/20 | 2019/20 | 2019/20 | 2019/20 | |
| E | ||||
| Other Expenditure-Research | 0 | 0 | 0 | |
| Total | 0 | 0 |
| Unrestricted | Restricted | Endowment | Total funds | Total funds | ||
|---|---|---|---|---|---|---|
| 2020/21 | 2020/21 | 2020/21 | 2020/21 | 2019/20 | ||
| E | E | |||||
| Debtor | - GMMH NHS FTTransactions | 743 | 743 | 74,208 | ||
| Totai | debtors fatling due in less than | 743 | 74,208 |
| Unrestricted | Restricted | Endowment | Total funds | Total funds | |||||
|---|---|---|---|---|---|---|---|---|---|
| 2020121 | 2020121 | 2020/21 | 2020/21 | 2019/20 | |||||
| 6 | 6 | ||||||||
| Cash | held | 'l4 | 31,386 | 137,291 | 15,000 | 183,677 | 95,365 | ||
| Royal | London Asset | Management | Inmstment | 202,180 | 0 | 0 | 202,180 | 189,453 | |
| Total | investments | and cash | 233,566 | 137,291 | 15,000 | 385,857 | 284,818 |
| Unrestricted | Restricted | Endowment | Total funds | Total funds | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2020/21 | 2020/21 | 2020/21 | 2020/21 | 2019/20 | ||||||
| E | E | |||||||||
| Creditors | under | 1 | year | |||||||
| Creditors | - | GMMM | NHS | FTTransactions | (10,166) | (16,979) | (27,145) | (104,026) | ||
| (10,166) | (16,979) | (27,146) | (104,026) |
| 1 April 2020 | 31 March 2021 | |||||||
|---|---|---|---|---|---|---|---|---|
| Number of individual funds |
Balance brought forward |
Incoming Resources |
Investment Gain!(Loss) |
Resources Expended |
Transfer | Balance carried forward |
||
| 8 | ||||||||
| Unrestricted | funds | |||||||
| Adult Secure Unit | 1 | 12,'l20 | 0 | 0 | 0 | 12,120 | ||
| Manchester | Senlces | 1 | 10,243 | 229 | 0 | 0 | 10,472 | |
| Research 8 | Innowt ton | 3 | 48,601 | 0 | 0 | (9,350) | 39,251 | |
| General Funds | 3 | 169,036 | 23,071 | 12,727 | (12,534) | (30,000) | 162,300 | |
| Resb icted funds | ||||||||
| Could 19 | 0 | 125,600 | (35,288) | 3o,ooo | 120,312 | |||
| Endowment | funds | |||||||
| ESMI | 15,000 | 15,000 | ||||||
| Total funds | 10 | 255,000 | 148,900 | 12,727 | (57,172) | 0 | 359;455 |
| Unresbicted | Restricted ' |
Endowment | Total funds | Total funds | ||||
|---|---|---|---|---|---|---|---|---|
| 2020/21 | 2020/21 | 2020/21 | 2020/21 | 2019/20 | ||||
| K | ||||||||
| Net income / (expenditure) for the reporting per the statement offinancial activities) |
period (as | (15,857) | 120,312 | 0 | 104,455 | (88,562) | ||
| Adjustments for. |
||||||||
| (Gains) / | losses on investments | (12,727) | 0 | 0 | (12,727) | 182 | ||
| Dividends, | interest and rents from in~tments |
(5,183) | 0 | 0 | (5,183) | (8,551) | ||
| Purchase | ofinvestment | 0 | 0 | 0 | 0 | 90,000 | ||
| (Increase) / decrease | in debtors | 73,464 | 0 | 0 | 73,464 | (74,007) | ||
| increase | / (decrease) | in creditors | (93,860) | 16,979 | 0 | (76,881) | 70,766 | |
| Net cash | provided | by (used in) operating | activities | (54,163) | 137,291 | 0 | 83,128 | (10,172) |
| Unrestricted | Restricted | Endowment | Total funds | Total funds | |||
|---|---|---|---|---|---|---|---|
| 31 March 2021 | 31 March 2021 | 31 INarch 2021 | 31 March 2021 | 31 March 2020 | |||
| E | |||||||
| Cash | at commerciai | bank and in hand | 31,386 | 137,291 | 15,000 | 183,677 | 95,365 |
| Total | cash and cash equivalents | 31,386 | 137,291 | 15,000 | 183,677 | 95,365 |